308 related articles for article (PubMed ID: 12377334)
1. Curative radiotherapy for primary orbital lymphoma.
Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas.
Esik O; Ikeda H; Mukai K; Kaneko A
Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for primary orbital lymphoma.
Chao CK; Lin HS; Devineni VR; Smith M
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):929-34. PubMed ID: 7860408
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy is successful treatment for orbital lymphoma.
Smitt MC; Donaldson SS
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):59-66. PubMed ID: 8482631
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in the management of orbital lymphoma.
Bolek TW; Moyses HM; Marcus RB; Gorden L; Maiese RL; Almasri NM; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):31-6. PubMed ID: 10219791
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
7. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
8. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Pelloski CE; Wilder RB; Ha CS; Hess MA; Cabanillas FF; Cox JD
Radiother Oncol; 2001 May; 59(2):145-51. PubMed ID: 11325442
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.
Martinet S; Ozsahin M; Belkacémi Y; Landmann C; Poortmans P; Oehlere C; Scandolaro L; Krengli M; Maingon P; Miralbell R; Studer G; Chauvet B; Marnitz S; Zouhair A; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):892-8. PubMed ID: 12605966
[TBL] [Abstract][Full Text] [Related]
11. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades.
Kharod SM; Herman MP; Morris CG; Lightsey J; Mendenhall WM; Mendenhall NP
Am J Clin Oncol; 2018 Jan; 41(1):100-106. PubMed ID: 26398063
[TBL] [Abstract][Full Text] [Related]
13. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.
Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R
Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558
[TBL] [Abstract][Full Text] [Related]
14. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma.
Hata M; Omura M; Koike I; Tomita N; Iijima Y; Tayama Y; Odagiri K; Minagawa Y; Ogino I; Inoue T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1387-93. PubMed ID: 20950950
[TBL] [Abstract][Full Text] [Related]
15. Orbital lymphoma: radiotherapy outcome and complications.
Stafford SL; Kozelsky TF; Garrity JA; Kurtin PJ; Leavitt JA; Martenson JA; Habermann TM
Radiother Oncol; 2001 May; 59(2):139-44. PubMed ID: 11325441
[TBL] [Abstract][Full Text] [Related]
16. Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eze C; Friedrich I; Hadi I; Schmidt-Hegemann NS; Hartoyo SN; Trauth R; Reitz D; Manapov F; Siefert A; Dreyling M; Belka C; Li M
Eur J Haematol; 2022 Jul; 109(1):21-30. PubMed ID: 35276022
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy.
Woolf DK; Kuhan H; Shoffren O; Akinnawo EM; Sivagurunathan B; Boyce H; Plowman PN
Clin Oncol (R Coll Radiol); 2015 Mar; 27(3):153-9. PubMed ID: 25455843
[TBL] [Abstract][Full Text] [Related]
19. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification.
Hasegawa M; Kojima M; Shioya M; Tamaki Y; Saitoh J; Sakurai H; Kitamoto Y; Suzuki Y; Niibe H; Nakano T
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):172-6. PubMed ID: 12909230
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization.
Lee J; Yoon JS; Kim JS; Koom WS; Cho J; Suh CO
Jpn J Clin Oncol; 2019 Jul; 49(7):664-670. PubMed ID: 31505651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
